[HTML][HTML] Confocal laser endomicroscopy for diagnosing malignant pleural effusions
S Zirlik, K Hildner, RJ Rieker, M Vieth… - … Medical Journal of …, 2018 - ncbi.nlm.nih.gov
Background Confocal laser endomicroscopy (CLE) enables “in vivo” microscopic tissue
diagnosis based on tissue reflectance or tissue fluorescence upon application of …
diagnosis based on tissue reflectance or tissue fluorescence upon application of …
Laricitrin suppresses increased benzo (a) pyrene-induced lung tumor-associated monocyte-derived dendritic cell cancer progression
WA Chang, JY Hung, YM Tsai, YL Hsu… - Oncology …, 2016 - spandidos-publications.com
Abstract Benzo (a) pyrene (BaP) stimulates lung cancer cells, promoting monocyte-derived
dendritic cells to secrete soluble factors, including heparin binding-epidermal growth factor …
dendritic cells to secrete soluble factors, including heparin binding-epidermal growth factor …
EGFR mutations in malignant pleural effusions from lung cancer
CJ Shamblin, NT Tanner, RS Sanchez… - Current Respiratory …, 2013 - Springer
A malignant pleural effusion (MPE) from lung cancer represents stage IV disease and
portends a poor prognosis. Routine mutational analysis of tissue samples is the standard of …
portends a poor prognosis. Routine mutational analysis of tissue samples is the standard of …
Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion
L Xu, B Wang, M Gao, Y Zhang, Q Qi, T Li, C Li… - Thoracic …, 2018 - Wiley Online Library
Background Malignant pleural effusion is a common complication of non‐small cell lung
cancer (NSCLC); however, treatment options remain limited. This study evaluated the safety …
cancer (NSCLC); however, treatment options remain limited. This study evaluated the safety …
[HTML][HTML] Sensitive cell-free tumor DNA analysis in supernatant pleural effusions supports therapy selection and disease monitoring of lung cancer patients
R de Kock, C Knoops, M Baselmans… - Cancer Treatment and …, 2021 - Elsevier
Supernatant pleural effusions (PE) have shown to be a valuable source for the detection of
driver mutations in circulating tumor DNA (ctDNA). In this prospective study, the clinical …
driver mutations in circulating tumor DNA (ctDNA). In this prospective study, the clinical …
Current and future options for the diagnosis of malignant pleural effusion
F Rodriguez-Panadero… - Expert Opinion on …, 2013 - Taylor & Francis
Introduction: Malignant pleural effusion (MPE) is a frequent problem faced by clinicians, but
tumor pleural involvement can be seen without effusion. Areas covered: Imaging, pleural …
tumor pleural involvement can be seen without effusion. Areas covered: Imaging, pleural …
PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometry
Objectives Pathologists encounter several challenges with programmed death ligand-1 (PD-
L1) immunohistochemistry (IHC) tests in malignant effusions, including lineage specification …
L1) immunohistochemistry (IHC) tests in malignant effusions, including lineage specification …